Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00792428 · ClinicalTrials.gov registry record · NA

Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery

A NA study of Stroke and Cerebrovascular Accident, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT00792428 is a NA study of Stroke and Cerebrovascular Accident that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00792428, a NA study of Stroke and Cerebrovascular Accident, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether a non-painful, non-invasive, brain-stimulation technique called transcranial direct current stimulation (tDCS) combined with traditional physical-occupational therapy (OT) will improve motor function in patients with chronic stroke. The aim is to determine the effect of applying real (anodal and/or cathodal) - in a dual configuration - vs sham (pretend) tDCS to the motor brain regions on both hemispheres - in a dual configuration - to improve motor function in chronic stroke patients. Our research in normal subjects has shown that motor skills can be enhanced if tDCS is applied to the brain's motor region during motor learning. The effects after a single session of tDCS can last for up to 30 minutes, effects of multiple sessions (one session per day) can last for weeks. Furthermore, single sessions of tDCS applied to the motor regions in stroke patients have shown that improvements in motor functions can be seen and that effects may last for at least 30 minutes. Patients enrolled in this trial will be randomized to receive either real tDCS or sham tDCS in combination with PT-OT once a day for 5 days. Assessments will be done about 3 days and 7 days after the end of the experimental treatment by investigators who are blinded to the intervention. Patients are also blinded as to whether they are receiving real or sham tDCS. We hypothesize that real tDCS applied to the motor regions in combination with PT-OT results in a subsequent improvement in motor function of the recovering hand over sham tDCS in combination with PT-OT.

Interventions

  • DEVICE Sham Transcranial Direct Current Stimulation
  • DEVICE Real Transcranial Direct Current Stimulation

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center / Harvard Medical School - Boston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2006-06
Est. Completion 2013-02-01
Phase NA

What the Registry Record Tells You About NCT00792428

The ClinicalTrials.gov registry entry for NCT00792428 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Sham Transcranial Direct Current Stimulation is the first listed.

NCT00792428 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00792428 about?

NCT00792428 is a clinical study titled "Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery". The purpose of this study is to determine whether a non-painful, non-invasive, brain-stimulation technique called transcranial direct current stimulation (tDCS) combined with traditional physical-occupational therapy (OT) will improve motor function in patients with chronic stroke. The aim is to det...

What is the current status of trial NCT00792428?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2006-06. Estimated completion is 2013-02-01.

What conditions does trial NCT00792428 study?

This clinical trial studies the following conditions: Stroke, Cerebrovascular Accident, Acute Stroke, CVA, Acute Cerebrovascular Accident.

What interventions are being tested in trial NCT00792428?

The interventions under investigation include: Sham Transcranial Direct Current Stimulation (DEVICE), Real Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT00792428?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00792428 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.